Lymphadenopathy -KEGG Pathway

May 23, 2022 Off By admin

Lymphadenopathy (HP:0002716)

KEGG Pathway

Index	Name	P-value	Adjusted p-value	Odds Ratio	Combined score
1	Autoimmune thyroid disease	9.117e-9	3.145e-7	271.31	5022.72
2	Allograft rejection	7.523e-7	0.00001038	244.35	3445.31
3	Primary immunodeficiency	7.523e-7	0.00001038	244.35	3445.31
4	Natural killer cell mediated cytotoxicity	2.740e-9	1.891e-7	157.65	3108.13
5	Graft-versus-host disease	0.000001023	0.00001083	219.24	3024.01
6	Type I diabetes mellitus	0.000001099	0.00001083	213.75	2932.86
7	Measles	4.542e-7	0.00001038	98.05	1431.99
8	African trypanosomiasis	0.0001485	0.0006402	142.54	1256.48
9	Th1 and Th2 cell differentiation	0.00001104	0.00009524	95.83	1093.80
10	Th17 cell differentiation	0.00001738	0.0001285	81.95	898.15
11	Apoptosis	0.00004054	0.0002543	61.21	618.98
12	Necroptosis	0.00005679	0.0003187	54.49	532.69
13	Hepatitis B	0.00006004	0.0003187	53.45	519.59
14	B cell receptor signaling pathway	0.0007138	0.002736	63.01	456.50
15	PI3K-Akt signaling pathway	0.00001863	0.0001285	37.41	407.42
16	Epstein-Barr virus infection	0.0001156	0.0005318	42.62	386.39
17	Hematopoietic cell lineage	0.001064	0.003678	51.27	351.00
18	Chagas disease	0.001128	0.003678	49.73	337.48
19	T cell receptor signaling pathway	0.001173	0.003678	48.75	328.95
20	NF-kappa B signaling pathway	0.001173	0.003678	48.75	328.95
21	FoxO signaling pathway	0.001851	0.005322	38.49	242.18
22	Cytokine-cytokine receptor interaction	0.0003530	0.001433	28.91	229.81
23	Pathways in cancer	0.00009084	0.0004477	24.62	229.14
24	Non-alcoholic fatty liver disease	0.002578	0.007016	32.41	193.21
25	Hepatitis C	0.002644	0.007016	31.99	189.89
26	JAK-STAT signaling pathway	0.002812	0.007185	30.98	182.00
27	Influenza A	0.003162	0.007793	29.15	167.78
28	Kaposi sarcoma-associated herpesvirus infection	0.003962	0.009426	25.91	143.34
29	Pathogenic Escherichia coli infection	0.004124	0.009485	25.38	139.35
30	Viral carcinogenesis	0.004372	0.009610	24.61	133.71
31	Viral myocarditis	0.02960	0.04982	37.53	132.12
32	Proteoglycans in cancer	0.004457	0.009610	24.37	131.91
33	Human immunodeficiency virus 1 infection	0.004758	0.009924	23.55	125.93
34	Lipid and atherosclerosis	0.004890	0.009924	23.21	123.50
35	Human T-cell leukemia virus 1 infection	0.005069	0.009993	22.78	120.38
36	Human cytomegalovirus infection	0.005343	0.01024	22.16	115.94
37	Acute myeloid leukemia	0.03301	0.05374	33.54	114.41
38	Fc epsilon RI signaling pathway	0.03349	0.05374	33.04	112.22
39	Ras signaling pathway	0.005670	0.01057	21.48	111.10
40	Herpes simplex virus 1 infection	0.001616	0.004848	16.88	108.49
41	Prolactin signaling pathway	0.03446	0.05387	32.08	108.04
42	Non-small cell lung cancer	0.03543	0.05387	31.17	104.12
43	p53 signaling pathway	0.03591	0.05387	30.74	102.25
44	Chronic myeloid leukemia	0.03736	0.05485	29.50	96.98
45	ErbB signaling pathway	0.04171	0.05995	26.33	83.66
46	MAPK signaling pathway	0.008965	0.01628	16.86	79.51
47	PD-L1 expression and PD-1 checkpoint pathway in cancer	0.04363	0.06144	25.13	78.70
48	Rheumatoid arthritis	0.04555	0.06286	24.03	74.23
49	Fc gamma R-mediated phagocytosis	0.04747	0.06366	23.03	70.18
50	AGE-RAGE signaling pathway in diabetic complications	0.04890	0.06366	22.32	67.37
51	Viral protein interaction with cytokine and cytokine receptor	0.04890	0.06366	22.32	67.37
52	Human papillomavirus infection	0.01126	0.01991	14.94	67.03
53	C-type lectin receptor signaling pathway	0.05081	0.06492	21.45	63.92
54	TNF signaling pathway	0.05462	0.06853	19.90	57.85
55	Neurotrophin signaling pathway	0.05794	0.07014	18.71	53.30
56	Growth hormone synthesis, secretion and action	0.05794	0.07014	18.71	53.30
57	Platelet activation	0.06031	0.07175	17.95	50.40
58	Osteoclast differentiation	0.06173	0.07219	17.52	48.78
59	Yersinia infection	0.06644	0.07641	16.22	43.98
60	Cell adhesion molecules	0.07160	0.07968	15.00	39.55
61	Phospholipase D signaling pathway	0.07160	0.07968	15.00	39.55
62	Pathways of neurodegeneration	0.02233	0.03851	10.32	39.22
63	Tuberculosis	0.08646	0.09469	12.30	30.10
64	Neutrophil extracellular trap formation	0.09060	0.09764	11.70	28.10
65	Chemokine signaling pathway	0.09198	0.09764	11.52	27.48
66	Coronavirus disease	0.1102	0.1152	9.50	20.97
67	Chemical carcinogenesis	0.1133	0.1167	9.22	20.08
68	Endocytosis	0.1191	0.1209	8.74	18.59
69	Alzheimer disease	0.1699	0.1699	5.92	10.50

Categoryautoimmunity

Autoimmunity -Lymphadenopathy

Autoimmunity-Lymphopenia